Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
SUMMARY Multipotent and pluripotent stem cells are potential sources for cell and tissue replacement therapies. For example, stem cell-derived red blood cells (RBCs) are a potential alternative to donated blood, but yield and quality remain a challenge. Here, we show that application of insight from human population genetic studies can enhance RBC production from stem cells. The SH2B3 gene encodes a negative regulator of cytokine signaling and naturally occurring loss-of-function variants in this gene increase RBC counts in vivo. Targeted suppression of SH2B3 in primary human hematopoietic stem and progenitor cells enhanced the maturation and overall yield of in vitro-derived RBCs. Moreover, inactivation of SH2B3 by CRISPR/Cas9 genome editing in human pluripotent stem cells allowed for enhanced erythroid cell expansion with preserved differentiation. Our findings therefore highlight the potential for combining human genome variation studies with genome editing approaches to improve cell and tissue production for regenerative medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Veres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474 · cited 1×
“We used CRISPR/Cas9-mediated genome editing to engineer isogenic hESC lines with either homozygous frameshift deletions in SH2B3 or intact WT alleles (Figures S2E and S2F) (Ding et al., 2013a, 2013b; Gupta and Musunuru, 2014; Veres et al., 2014).”
Self-citationSturgeon, C. M., Ditadi, A., Awong, G., Kennedy, M., & Keller, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2915 · Cited by 467 · cited 3×
“While PSC erythroid differentiation protocols continue to undergo refinement, are not yet optimized for RBC manufacture, and primarily produce the earliest waves of hematopoiesis equivalent to those that developmentally arise from the yolk sac (Kobari et al., 2012; Slukvin, 2013; Sturgeon et al., 2014), the current fi…”
Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059890 · Cited by 418 · cited 1×
“Despite promising recent advances (Hirose et al., 2013; Huang et al., 2014; Kurita et al., 2013), no immortalized human cell lines allow consistent differentiation into mature RBCs.”
The switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333
Self-citationAltered translation of GATA1 in Diamond-Blackfan anemia
Ludwig, L. S., Gazda, H. T., Eng, J. C., Eichhorn, S. W., Thiru, P., Ghazvinian, R., George, T. I., Gotlib, J. R., Beggs, A. H., Sieff, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3557 · Cited by 302
Self-citation
Cited by
Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis
Khajuria, R. K., Munschauer, M., Ulirsch, J. C., Fiorini, C., Ludwig, L. S., McFarland, S. K., Abdulhay, N. J., Specht, H., Keshishian, H., Mani, D. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.036 · Cited by 416
“We utilized an in vitro erythroid differentiation protocol from human HSPCs to interrogate GATA1 expression during this differentiation process (Giani et al., 2016; Kim et al., 2017).”
MethodSystematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits
Ulirsch, J. C., Nandakumar, S. K., Wang, L., Giani, F. C., Zhang, X., Rogov, P., Melnikov, A., McDonel, P., Do, R., Mikkelsen, T. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.048 · Cited by 328
Self-citationMassively parallel single-cell mitochondrial DNA genotyping and chromatin profiling
Lareau, C. A., Ludwig, L. S., Muus, C., Gohil, S. H., Zhao, T., Chiang, Z., Pelka, K., Verboon, J. M., Luo, W., Christian, E., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0645-6 · Cited by 315
Self-citationInterrogation of human hematopoiesis at single-cell and single-variant resolution
Ulirsch, J. C., Lareau, C. A., Bao, E. L., Ludwig, L. S., Guo, M. H., Benner, C., Satpathy, A. T., Kartha, V. K., Salem, R. M., Hirschhorn, J. N., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0362-6 · Cited by 208
Self-citationTrakarnsanga, K., Griffiths, R. E., Wilson, M. C., Blair, A., Satchwell, T. J., Meinders, M., Cogan, N., Kupzig, S., Kurita, R., Nakamura, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14750 · Cited by 204
“Diverse lines could be generated from individuals with rare blood group phenotypes or generated by genome-editing technologies 31,32 such as CRISPR, to meet unmet clinical need.”
Background
Metadata
- Authors
- Giani, F. C., Fiorini, C., Wakabayashi, A., Ludwig, L. S., Salem, R. M., Jobaliya, C. D., Regan, S. N., Ulirsch, J. C., Liang, G., Steinberg-Shemer, O., Guo, M. H., Esko, T., Tong, W., Brugnara, C., Hirschhorn, J. N., Weiss, M. J., Zon, L. I., Chou, S. T., French, D. L., Musunuru, K., & Sankaran, V. G.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 18
- Issue
- 1
- Pages
- 73-78
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W1811026913
- Cited by
- 86
- References
- 5
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.